Sigyn Therapeutics Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sigyn Therapeutics Inc's ROI in the third quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Sigyn Therapeutics Inc 's return on investment (ROI) in its third quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-4	-5	-5	-2	-4
Return On Investment (TTM)	-	-	-	-	-
RSAP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-3	-4	-3	-3	-4

RSAP Company Profile >> Back to RSAP Roi Comparisons >> See Annual RSAP Return On Investment

Return On Investment RSAP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Sigyn Therapeutics Inc's III. Quarter Investments	$ -4 Millions	RSAP's Balance sheet
Sigyn Therapeutics Inc's III. Quarter Income	$ -1 Millions	Quarterly RSAP's Income Statement
RSAP's Income by Division		See RSAP's Income by Division

RSAP Annual Return On Investment	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020
Total Investments in Millions	-4	-3	-2	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-3	-4	-3	-3	-1
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-1269.98 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RSAP's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RSAP's Competitors
Subscribers only: Roi for Sigyn Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RSAP's Customers

Other Ratios
RSAP's Roa	RSAP's Inventory Turnover Ratio	RSAP's Growth Rates	RSAP's Dividend Statistics
	RSAP's Profitability Ratios	RSAP's Asset Turnover Ratio	RSAP's Dividend Growth
RSAP's Roe	RSAP's Valuation Ratios	RSAP's Financial Strength Ratios	RSAP's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector	ROI
Biomx Inc	138.01 %
Emmis Acquisition Corp	132.78 %
Kyntra Bio Inc	108.42 %
Oak Woods Acquisition Corp	106.75 %
Coherus Oncology inc	101.27 %
Stablecoin Development Corporation	94.92 %
Rigel Pharmaceuticals Inc	93.34 %
Silexion Therapeutics Corp	87.06 %
Interpace Biosciences Inc	77.75 %
Tg Therapeutics Inc	75.13 %
Arcutis Biotherapeutics Inc	71.66 %
Earth Science Tech Inc	68.50 %
Capforce Inc	65.08 %
Exelixis Inc	63.48 %
Cormedix Inc	56.64 %
Abeona Therapeutics Inc	55.42 %
Idexx Laboratories Inc	47.31 %
Adma Biologics Inc	44.57 %
Novavax inc	43.59 %
Ptc Therapeutics inc	43.15 %
Medinotec Inc	41.78 %
Dariohealth Corp	41.32 %
Entera Bio Ltd	37.53 %
Mettler toledo International Inc	35.51 %
Siga Technologies Inc	33.53 %
Cytomx Therapeutics Inc	33.34 %
Sbc Medical Group Holdings Incorporated	33.23 %
Halozyme Therapeutics Inc	32.75 %
Medpace Holdings Inc	31.78 %
Puma Biotechnology Inc	31.53 %

Date modified: 2026-09-08T15:11:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.